NeoGenomics Inc (NAS:NEO)
$ 16.66 0.46 (2.84%) Market Cap: 2.14 Bil Enterprise Value: 2.35 Bil PE Ratio: 0 PB Ratio: 2.33 GF Score: 77/100

Neogenomics Inc at Goldman Sachs Healthcare Conference Transcript

Jun 14, 2023 / 06:20PM GMT
Release Date Price: $16.63 (+2.21%)
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst

All right. It's great. Thanks, everyone, for joining us. I'm Matt Sykes for the Life Science Tools and Diagnostics Analyst at Goldman Sachs. I have the pleasure of having the senior management team from NeoGenomics here today. Chris Smith, the CEO; Jeff Sherman, the CFO; and Warren Stone, President of Clinical Services.

Chris, Jeff, Warren, thank you very much for joining us.

Christopher Michael Smith
NeoGenomics, Inc. - CEO & Director

Yes. Good to be here.

Jeffrey S. Sherman
NeoGenomics, Inc. - CFO

Thank you.

Questions & Answers

Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst

Maybe if we'll start out, Chris, and you guys can chime in as well, just sort of set the stage in terms of talking about first quarter results and some of the trends you're seeing in the business and what your expectations are for the second half

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot